We are live on
!
Find out more
SLT
St Louis Trust Portfolio holdings
AUM
$856M
1-Year Est. Return
18.9%
This Fund
S&P 500
This Quarter
Est. Return
+9.36%
1 Year Est. Return
+18.9%
3 Year Est. Return
+52.3%
5 Year Est. Return
+51.23%
10 Year Est. Return
+178.74%
AUM
$751M
AUM Growth
+$60.4M
(+8.7%)
Cap. Flow
-$1.56M
Cap. Flow
% of AUM
-0.21%
Top 10 Holdings %
Top 10 Hldgs %
65.8%
Holding
126
New
6
Increased
24
Reduced
14
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Schwab US Large- Cap ETF
SCHX
|
+$5.52M |
| 2 |
Vanguard Total International Stock ETF
VXUS
|
+$5.06M |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$2.74M |
| 4 |
Schwab U.S Small- Cap ETF
SCHA
|
+$2.41M |
| 5 |
Vanguard Russell 2000 ETF
VTWO
|
+$1.51M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$21.6M |
| 2 |
iShares S&P Small-Cap 600 Growth ETF
IJT
|
+$1.57M |
| 3 |
iShares S&P Small-Cap 600 Value ETF
IJS
|
+$1.47M |
| 4 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$1.29M |
| 5 |
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
|
+$680K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 2.39% |
| 2 | Consumer Staples | 1.36% |
| 3 | Healthcare | 1.34% |
| 4 | Industrials | 1.06% |
| 5 | Technology | 0.89% |
Similar funds
QIM
BIM
USGIU
TIM
NOCM
OAM
ACP
GIP
St Louis Trust's Q2 2025 Portfolio in Review
As of Q2 2025, St Louis Trust held 126 positions worth $751M, up 8.7% from $690M the previous quarter. Its ten largest holdings account for 66% of the portfolio.
St Louis Trust's Q2 2025 filing shows 6 new, 24 increased, 14 reduced and 4 closed positions. Its largest new stake was Vanguard S&P Small-Cap 600 Value ETF: 16,300 shares worth $1.39M. The largest sale was Intra-Cellular Therapies Inc., an estimated $21.6M.
By sector, the portfolio is most concentrated in Financials at 2.4% of assets, down from 2.5% a quarter earlier, followed by Consumer Staples and Healthcare.
- St Louis Trust's largest Q2 2025 buy was Vanguard S&P Small-Cap 600 Value ETF: 16,300 shares worth $1.39M.
- St Louis Trust added most to Schwab US Large- Cap ETF in Q2 2025, an estimated $5.52M increase.
- St Louis Trust's biggest Q2 2025 reduction was iShares S&P Small-Cap 600 Value ETF, cutting an estimated $1.47M.
- St Louis Trust fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $21.6M.
- St Louis Trust's ten largest holdings make up 66% of its $751M portfolio in Q2 2025.
- St Louis Trust opened 6 new positions and closed 4 in Q2 2025.
- St Louis Trust's portfolio value rose 8.7% quarter-over-quarter to $751M.
Based on St Louis Trust's 13F filing for Q2 2025, filed 25 Jul 2025.